STATE STREET CORP - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 213 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$89,729,776
+40.5%
101,275,142
+149.0%
0.00%
-25.0%
Q3 2022$63,851,000
-19.9%
40,669,276
+2.5%
0.00%
-20.0%
Q2 2022$79,719,000
+0.7%
39,661,099
+16.8%
0.01%
+25.0%
Q1 2022$79,129,000
+16.6%
33,960,884
+132.7%
0.00%
+33.3%
Q4 2021$67,870,000
-27.6%
14,595,754
+18.8%
0.00%
-40.0%
Q3 2021$93,753,000
-5.4%
12,287,375
+20.1%
0.01%0.0%
Q2 2021$99,153,000
+22.5%
10,232,527
+4.6%
0.01%0.0%
Q1 2021$80,937,000
-6.4%
9,786,760
-22.8%
0.01%0.0%
Q4 2020$86,508,000
-33.7%
12,675,183
+8.3%
0.01%
-44.4%
Q3 2020$130,551,000
+108.1%
11,708,587
+17.2%
0.01%
+80.0%
Q2 2020$62,740,000
+1381.5%
9,990,515
+334.1%
0.01%
Q1 2020$4,235,000
-45.2%
2,301,587
+0.6%
0.00%
-100.0%
Q4 2019$7,730,000
+58.8%
2,286,913
+0.5%
0.00%
Q3 2019$4,868,000
-19.8%
2,274,705
+0.0%
0.00%
Q2 2019$6,072,000
-39.6%
2,274,194
+7.4%
0.00%
-100.0%
Q1 2019$10,057,000
-30.7%
2,117,328
-65.0%
0.00%0.0%
Q4 2018$14,522,000
-52.6%
6,050,798
-13.0%
0.00%
-50.0%
Q3 2018$30,611,000
-41.2%
6,957,785
-3.8%
0.00%
-50.0%
Q2 2018$52,067,000
+96.0%
7,232,063
+40.2%
0.00%
+100.0%
Q1 2018$26,566,000
+33527.8%
5,158,346
+24526.9%
0.00%
Q4 2017$79,000
+229.2%
20,946
+52.9%
0.00%
Q3 2017$24,000
-11.1%
13,7000.0%0.00%
Q2 2017$27,000
-98.7%
13,700
-97.3%
0.00%
Q1 2017$2,029,000
-19.5%
513,168
-0.3%
0.00%
Q4 2016$2,519,000
-32.9%
514,597
+6.0%
0.00%
Q3 2016$3,756,000
+39.4%
485,521
+0.9%
0.00%
Q2 2016$2,694,000
+2.0%
481,317
-2.0%
0.00%
Q1 2016$2,642,000
-30.5%
491,085
+12.5%
0.00%
Q4 2015$3,799,000
+6.6%
436,525
+2.8%
0.00%
Q3 2015$3,564,000
-31.1%
424,752
+44.8%
0.00%
-100.0%
Q2 2015$5,171,000
+3541.5%
293,275
+2284.3%
0.00%
Q1 2015$142,000
+10.9%
12,300
-3.1%
0.00%
Q4 2014$128,000
+172.3%
12,700
+21.0%
0.00%
Q3 2014$47,000
-33.8%
10,5000.0%0.00%
Q2 2014$71,00010,5000.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Paloma Partners Management Co 3,775,000$1,359,0000.05%
Oaktree Fund Advisors, LLC 66,000$23,7600.02%
GoalVest Advisory LLC 32,915$11,8490.01%
Houlihan Financial Resource Group, Ltd. 30,000$110.01%
Granite Bay Wealth Management, LLC 22,520$80.01%
S&T BANK/PA 38,853$140.00%
Lattice Capital Management, LLC 51,800$18,6480.00%
Modus Advisors, LLC 19,706$7,0940.00%
Crescent Grove Advisors, LLC 60,000$21,6000.00%
SlateStone Wealth, LLC 21,433$80.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders